Anti-PCSK9 antibody and use thereof
US10858447B2 · kind B2 · utility
0Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 24, 2016 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Nov 24, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an antibody or a functional fragment thereof that specifically binds to Proprotein convertase subtilisin/kexin type 9 (PCSK9) with high affinity, also provides a nucleic acid molecule encoding the antibody of the invention or the functional fragment thereof, for expressing an expression vector and a host cell of the antibody or the functional fragment thereof, and also provides a method for producing the antibody or the functional fragment thereof. The present invention provides that the antibody or the functional fragment thereof is used for treating diseases such as dyslipidemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.